Measles and rubella vaccine “Mabella” launched by Vaccine maker Indian Immunologicals (IIL) for children
- Measles and rubella vaccine “Mabella” launched by Vaccine maker Indian Immunologicals (IIL) for children.
- This live-attenuated MR vaccine has been developed in an exclusive partnership with the Polyvac Institute of Vietnam.
- Mabella was launched as part of the 25th celebrations of the IIL division Human Biologicals Institute (HBI) in Udhagamandalam (Ooty), Tamil Nadu.
- The vaccine has been proven to be safe and effective through extensive human clinical trials.
- It will addresses the urgent need to control the deadly measles and rubella that kill nearly a million children globally.
- In 1998, the Human Biological Institute (HBI), a division of IIL, was established at a time when the need for indigenous vaccines was paramount.
- It developed India’s first safe vero-cell rabies vaccine – Abhayrab in 1998, which paved the way for phasing out painful nerve tissue vaccines.
